# Phase 1 depression trials recruiting: 25 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 25 trials in phase 1 for depression that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 1 depression trials: 25 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-1/depression

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 25
- Recruiting or not yet: 25
- Read on: November 19, 2026

## Trials

The 25 newest of 25, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| October 16, 2026 | NCT07878754 | Remote Medical Monitoring of Patients With Depression | ThIA Santé Mentale | Phase 1 | Recruiting | Depression Chronic, Depression and Quality of Life, Depression, Major Depressive Episode | 608 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07878754) |
| September 22, 2026 | NCT07833761 | ADEPT Psilocybin-Assisted Therapy With DBT for Borderline Personality Disorder | University of Minnesota | Phase 1 | Not yet recruiting | Borderline Personality Disorder, Borderline Personality Pathology, Depressive Symptoms, Emotion Dysregulation, Suicidal... | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07833761) |
| July 6, 2026 | NCT07683988 | Oral and Sublingual Ketamine | Western University, Canada | Phase 1 | Not yet recruiting | Major Depression Severe | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07683988) |
| May 27, 2026 | NCT07607938 | Psilocybin as a Novel Therapy for Residual Anhedonia | NYU Langone Health | Phase 1 | Recruiting | Anhedonia, Emotional Blunting | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07607938) |
| May 1, 2026 | NCT07562074 | Transcranial Magnetic Stimulation for Depression in Multiple Sclerosis | University of Calgary | Phase 1 | Not yet recruiting | Multiple Sclerosis, Depression - Major Depressive Disorder, Fatigue | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07562074) |
| March 31, 2026 | NCT07503002 | Shortened LSD Intervention for Major Depressive Disorder | Johns Hopkins University | Phase 1 | Not yet recruiting | Major Depression Moderate, Major Depression Severe, Major Depression | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07503002) |
| March 24, 2026 | NCT07490353 | Elucidating the Relevance of the Psychedelic Experience to Psilocybin's Anti-Anhedonic Effects | Medical University of Vienna | Phase 1 | Recruiting | Depression - Major Depressive Disorder, Anhedonia | 85 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07490353) |
| August 24, 2025 | NCT07139834 | Pattern Separation in Major Depressive Disorder | Sponsor not shown (see the record) | Phase 1 | Recruiting | Major Depressive Disorder (MDD) | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07139834) |
| June 24, 2025 | NCT07033780 | Theta-Burst Stimulation to Treat Depression | Centre for Addiction and Mental Health | Phase 1 | Recruiting | Major Depressive Disorder (MDD) | 84 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07033780) |
| March 14, 2025 | NCT06876129 | Pharmacologic Augmentation of TMS for Depression With D-serine | Mclean Hospital | Phase 1 | Recruiting | Depression | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06876129) |
| January 10, 2025 | NCT06767566 | Ketamine Pharmacokinetics and Pharmacodynamics for Postpartum Depression and Pain After Cesarean Delivery | University of Utah | Phase 1 | Recruiting | Pain, Postpartum Depression | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06767566) |
| November 5, 2024 | NCT06675240 | Meditative Neurofeedback for Depression | University of California, San Diego | Phase 1 | Recruiting | Depression - Major Depressive Disorder, Depression Disorders | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06675240) |
| November 4, 2024 | NCT06671977 | Study of the Safety, Tolerability, Electrophysiological Effects and Efficacy of DMT in Humans | Sponsor not shown (see the record) | Phase 1 | Recruiting | Major Depression Disorder, Depression | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06671977) |
| October 16, 2024 | NCT06644573 | Evaluating the Efficacy and Safety of PROSOMNIA Sleep Therapy™ in Patients With Sleep Deprivation and Chronic Insomnia | Sponsor not shown (see the record) | Phase 1 | Not yet recruiting | Chronic Insomnia, Sleep Deprivation, REM Behavior Disorder, REM Sleep Behavior Disorder, REM Sleep Measurement... | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06644573) |
| June 28, 2024 | NCT06480201 | Gamma Oscillations as a Prognostic Marker for Ketamine Therapy in Treatment Resistant Depression | Texas A&M University | Phase 1 | Recruiting | Healthy, Major Depressive Disorder, Treatment Resistant Depression | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06480201) |
| June 4, 2024 | NCT06442423 | Open-Label Psilocybin Study in Transdiagnostic Population | Yale University | Phase 1 | Recruiting | Transdiagnostic, Depression - Major Depressive Disorder, Anxiety, PTSD Symptoms, PTSD, Substance Use, Substance Use... | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06442423) |
| April 9, 2024 | NCT06355414 | Psilocybin in Chronic Low Back Pain and Depression | Johns Hopkins University | Phase 1 | Recruiting | Chronic Low-back Pain, Depression | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06355414) |
| October 17, 2023 | NCT06085937 | Feasibility and Safety of Ketamine for Suicidal Patients in the Emergency Department | Sponsor not shown (see the record) | Phase 1 | Recruiting | Suicide, Suicidal Ideation, Depression | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06085937) |
| January 30, 2023 | NCT05703685 | \[18F\]PF-06445974 to Image PDE4B in Major Depressive Disorder Using PET | National Institute of Mental Health (NIMH) | Phase 1 | Recruiting | Depression | 108 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05703685) |
| March 9, 2021 | NCT04789148 | Effects of Intranasal Oxytocin in Patients With Arginine-vasopressin Deficiency | Sponsor not shown (see the record) | Phase 1 | Recruiting | Vasopressin Deficiency | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04789148) |
| January 15, 2021 | NCT04711915 | Fixed Order, Open-Label, Dose-Escalation Study of DMT in Humans | Yale University | Phase 1 | Recruiting | Major Depressive Disorder, Depression | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04711915) |
| October 12, 2020 | NCT04582916 | PET Imaging of Cyclooxygenase in Participants With Major Depressive Disorder (MDD) | National Institute of Mental Health (NIMH) | Phase 1 | Recruiting | Depression | 64 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04582916) |
| July 20, 2020 | NCT04478305 | Affect of Duavive on Mood & Anxiety Symptoms | St. Joseph's Healthcare Hamilton | Phase 1 | Recruiting | Menopause, Depression, Anxiety, Sleep, Menopause Related Conditions | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04478305) |
| June 4, 2019 | NCT03973268 | Mechanism of Action Underlying Ketamine's Antidepressant Effects: The AMPA Throughput Theory in Patients With Treatment-Resistant Major... | National Institute of Mental Health (NIMH) | Phase 1 | Recruiting | Depression, Major Depressive Disorder, Major Depression | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03973268) |
| February 27, 2017 | NCT03065335 | Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder | National Institute of Mental Health (NIMH) | Phase 1 | Recruiting | Healthy Volunteer, Major Depressive Disorder, Depression | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03065335) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| National Institute of Mental Health (NIMH) | 4 |
| Yale University | 2 |
| Johns Hopkins University | 2 |
| University of Minnesota | 1 |
| University of Utah | 1 |
| Medical University of Vienna | 1 |
| ThIA Santé Mentale | 1 |
| University of Calgary | 1 |
| University of California, San Diego | 1 |
| Texas A&M University | 1 |
| NYU Langone Health | 1 |
| Western University, Canada | 1 |
| Mclean Hospital | 1 |
| St. Joseph's Healthcare Hamilton | 1 |
| Centre for Addiction and Mental Health | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 19 |
| Canada | 3 |
| Austria | 1 |
| France | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Pediatric nephrology practices in the United States](https://specstream.ai/data/businesses/pediatric-nephrology-practices/united-states)
- [Wills, trusts and probate law firms in the United States](https://specstream.ai/data/businesses/wills-trusts-and-probate-law-firms/united-states)
- [Dermatology practices in the United States](https://specstream.ai/data/businesses/dermatology-practices/united-states)
- [Livestock feed and supply stores in the United States](https://specstream.ai/data/businesses/livestock-feed-and-supply-stores/united-states)
- [Sports medicine clinics in the United States](https://specstream.ai/data/businesses/sports-medicine-clinics/united-states)
- [British restaurants in the United States](https://specstream.ai/data/businesses/british-restaurants/united-states)
